Clinical Trial Update: Single Dose Escalation Study of PF-04360365 In Subjects With Mild To Moderate Alzheimer's Disease [Phase 1]

View source ↗

Summary

Pfizer conducted a Phase 1 single-dose escalation study of PF-04360365 in adults with mild to moderate Alzheimer's disease; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• PF-04360365

Snippet

Sponsor: Pfizer | Conditions: Alzheimer's Disease | Phase 1 | Status: COMPLETED